Acumetis
  • Home
  • About Us
    • About Us Overview
      • ESG
    • Acumetis appoints Ramil Burden as Chief Executive Officer
  • Expertise
    • Expertise Overview
      • Commercial Strategy
      • Launch Excellence
      • Patient Access & Support Services
      • Global Value & Access
      • Insights & Analytics
      • Medical Affairs
    • Meet Acumetis at ISPOR EU 2026
  • Solutions
    • Solutions
      • Turn-around-time assessment
      • Model Builder
    • First Joint Clinical Assessment (JCA) Report Published
  • Resources
    • Topics
      • Most Favored Nation
      • Direct-to-Patient
    • Resources Overview
      • Articles
      • Case Studies
      • Policy
      • Assessments
      • Trends
    • How to turn patient insights into cross-functional decisions
  • Careers
Contact Us
Acumetis
  • Home
  • About Us
    • About Us Overview
      • ESG
    • Acumetis appoints Ramil Burden as Chief Executive Officer
  • Expertise
    • Expertise Overview
      • Commercial Strategy
      • Launch Excellence
      • Patient Access & Support Services
      • Global Value & Access
      • Insights & Analytics
      • Medical Affairs
    • Meet Acumetis at ISPOR EU 2026
  • Solutions
    • Solutions
      • Turn-around-time assessment
      • Model Builder
    • First Joint Clinical Assessment (JCA) Report Published
  • Resources
    • Topics
      • Most Favored Nation
      • Direct-to-Patient
    • Resources Overview
      • Articles
      • Case Studies
      • Policy
      • Assessments
      • Trends
    • How to turn patient insights into cross-functional decisions
  • Careers
Contact Us

Articles
Access by design: Market access thinking across the drug development lifecycle
Watch the interview to learn how evolving regulatory and HTA requirements are reshaping market access strategy.
Read More
Articles
Why Most Favored Nation pricing is becoming a political imperative
Explore how Most Favored Nation (MFN) pricing could impact pharmaceutical pricing, reimbursement, market access, and evidence strategies for life sciences organizations.
Read More
Articles
How to navigate loss of exclusivity with a strategic commercial playbook
Download the playbook to learn how leading organizations prepare for and manage loss of exclusivity.
Read More
Evaluating direct-to-employer as an alternative access channel for manufacturers
Learn how Acumetis evaluated a direct-to-employer strategy, identify partnership opportunities, and develop a roadmap to support GTN improvement and future commercialization decisions.
Read More
Articles
World EPA congress logo on background
Meet Acumetis at World EPA 2027!
Meet the Acumetis GVA team at World EPA 2027 in Amsterdam as a Platinum Sponsor, exploring evidence, pricing, reimbursement, and access strategies across global markets.
Read More
Case Studies
Abstract image looking up the side of building
FRM Proactivity: Reduce enrollment errors and accelerate turnaround time
Discover how proactive FRM engagement, data-driven case prioritization, and cross-functional tracking improved efficiency, reduced enrollment errors, and accelerated patient access.
Read More
Articles
Field reimbursement manager meeting with a healthcare provider about patient onboarding and prior authorization
Transforming field reimbursement managers: reactive to proactive strategic enablement
Learn how proactive, data-driven solutions help reduce access barriers, improve account planning, and accelerate patient onboarding.
Read More
Articles
Woman sitting back working on laptop
Advancing patient-centered medical publications through publication extenders
At ISMPP 2025, a clear imperative emerged: the future of medical publications reporting must be more inclusive, accessible, and patient-centered. Read the article here
Read More
Assessments
Woman talking to man in office
Operational Health Assessment: A rapid path to patient services optimization
Learn how proactive, data-driven solutions help reduce access barriers, improve account planning, and accelerate patient onboarding.
Read More
1 2 3 4 … 8

Resources

  • Articles
  • Assessments
  • Case Studies
  • Direct-to-Patient
  • Most Favored Nation
  • Policy
  • Resource
  • Trends

Share Our Blog!

Acumetis Logo
Reframe
what's
possible.
Contact Us
Navigation
  • About Us
  • Expertise
  • Careers
  • ESG
  • Marketing Communications
  • Privacy Policy
  • Cookies Policy
Copyright © 2026 Acumetis. All rights reserved.